Investor · Boston, MA

Kevin G. Lafond

Open Kevin in the network graph →

Filings

5

SEC Form D

Connections

59

co-filers

Capital

$227.5M

across filings

Active

Oct 2014

to Nov 2018

Most-connected co-filers (59)

James A. Cannon · Boston, MA5 shared Randal J. Kirk · Boston, MA4 shared Murray Brennan · Boston, MA4 shared Michael Weiser · Boston, MA4 shared Caesar Belbel · Boston, MA4 shared Matthew Zalosh · Boston, MA3 shared John J. Tobin · Seattle, WA3 shared Bradford G. Jackson · Seattle, WA3 shared James D. Mitchell · Seattle, WA3 shared Michael D. Heffernan · Seattle, WA2 shared Shenkman Capital Management, Inc · New York, NY2 shared T. M. White · PALO ALTO, CA2 shared Steven Heim · Boston, MA2 shared Mark L. Friedman · Boca Raton, FL2 shared Reza W. Zadno · San Francisco, CA2 shared Bryan J. Weeks · Seattle, WA2 shared Marcee M. Maroney · PALO ALTO, CA2 shared Pccp Credit Vi GP, LLC · Los Angeles, CA2 shared Hayley M. Lewis · PALO ALTO, CA2 shared Guy Nohra · San Clemente, CA2 shared Paul S. Dennis · Delray Beach, FL2 shared Jon D. Ryan · Boca Raton, FL2 shared David M. Gravett · PALO ALTO, CA2 shared Gary O. Marino · Boca Raton, FL2 shared

Recent filings (5)

ZIOPHARM ONCOLOGY INCNov 2018 · 26 co-filers$107.0M ZIOPHARM ONCOLOGY INCJul 2016 · 24 co-filers$120.0M Carbylan Therapeutics, Inc.Mar 2015 · 26 co-filers$4.0M ZIOPHARM ONCOLOGY INCJan 2015 · 20 co-filers$57.5M Carbylan Therapeutics, Inc.Oct 2014 · 22 co-filers$5.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Kevin in the interactive graph →